Product Information
PREGABALIN 20 MG/ML SOLUTION is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.1530 per ML under NDC 59762157601. Its NADAC has been published 185 times since Mar 22, 2023.
FDA first approved this application on Jan 4, 2010. Its Orange Book therapeutic-equivalence code is AA.
The High Outlier badge above means this manufacturer's average price in the Pregabalin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
20 mg/mL
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762157601
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PREGABALINApproval Type
Authorized Generic (NDA)
FDA Application
NDA022488FDA Approved
1/4/2010
TE Code
AA
On Market Since
7/29/2019
Price Statistics
The NADAC for PREGABALIN 20 MG/ML SOLUTION has been published 185 times since Mar 22, 2023, and over the history we have for it it has risen 27.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1530 per ML |
|---|---|
| All-time high | $0.1660 (Mar 11, 2026) |
| All-time low | $0.1052 (Sep 20, 2023) |
| 52-week high | $0.1660 |
| 52-week low | $0.1505 |
| Median price | $0.1412 |
| Average price | $0.1358 |
| Largest weekly change | +27.3% (Apr 17, 2024) |
| Weeks tracked | 185 |
| Tracking since | Mar 22, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Pregabalin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PREGABALIN 20 MG/ML SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for PREGABALIN 20 MG/ML SOLUTION, manufactured by Mylan Pharmaceuticals Inc., is $0.1530 per ML (NDC 59762157601), effective Sep 30, 2026.
How has the price of PREGABALIN 20 MG/ML SOLUTION changed over time?
Over the history we have for it, the NADAC for PREGABALIN 20 MG/ML SOLUTION has risen 27.6%. It has been tracked across 185 weekly CMS publications since Mar 22, 2023.
What are the highest and lowest recorded NADAC prices for PREGABALIN 20 MG/ML SOLUTION?
Since Mar 22, 2023, the NADAC for PREGABALIN 20 MG/ML SOLUTION has ranged from a low of $0.1052 (Sep 20, 2023) to a high of $0.1660 (Mar 11, 2026), with a median of $0.1412 per ML.
Are there cheaper alternatives to PREGABALIN 20 MG/ML SOLUTION?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as PREGABALIN 20 MG/ML SOLUTION in a comparable dosage form, but none are currently priced below it.
Who manufactures PREGABALIN 20 MG/ML SOLUTION?
PREGABALIN 20 MG/ML SOLUTION (NDC 59762157601) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.